| Enzo |
ALX-167-004-P001 |
Somatostatin 14
|
1mg* |
|
|
| Enzo |
ALX-168-009-R050 |
L-TAT control peptide
|
50µl |
|
|
| Enzo |
ALX-167-003-M001 |
Substance P
|
1mg |
|
|
| Enzo |
ALX-167-003-M005 |
Substance P
|
5mg |
|
|
| Enzo |
ALX-165-026-M001 |
PACAP (human, sheep, rat) (6-38)
|
1mg |
|
|
| Enzo |
ALX-165-066-M002 |
Pam3Cys-Ser-(Lys)4 . trihydrochloride
|
2mg |
|
|
| Enzo |
ALX-165-069-M001 |
Pam3Cys-Ser-(Lys)4 (Aca-Aca-Biotin) . 2 trifluoroacetate
|
1mg |
|
|
| Enzo |
ALX-165-071-M001 |
PHC-SKKKK 3 TFA
|
1mg |
|
|
| Enzo |
ALX-166-001-M001 |
Ras inhibitory peptide
|
1mg |
|
|
| Enzo |
ALX-165-025-MC05 |
PACAP (human, sheep, rat) (1-38)
|
0.5mg |
|
|
| Enzo |
ALX-165-025-M001 |
PACAP (human, sheep, rat) (1-38)
|
1mg |
|
|
| Enzo |
ALX-165-024-M001 |
PKI-tide
|
1mg |
|
|
| Enzo |
ALX-165-024-M005 |
PKI-tide
|
5mg |
|
|
| Enzo |
ALX-165-022-M001 |
[pTyr527] pp60c-src (521-533)
|
1mg |
|
|
| Enzo |
ALX-165-022-MC05 |
[pTyr527] pp60c-src (521-533)
|
0.5mg |
|
|
| Enzo |
ALX-165-017-M001 |
[Ser25] Protein kinase C (19-31)
|
1mg |
|
|
| Enzo |
ALX-165-017-M005 |
[Ser25] Protein kinase C (19-31)
|
5mg |
|
|
| Enzo |
ALX-165-009-M005 |
Protein kinase C (19-31)
|
5mg |
|
|
| Enzo |
ALX-165-009-M001 |
Protein kinase C (19-31)
|
1mg |
|
|
| Enzo |
ALX-165-007-MC01 |
Phospholipase A2 activating peptide
|
0.1mg |
|
|
| Enzo |
ALX-165-007-M001 |
Phospholipase A2 activating peptide
|
1mg |
|
|
| Enzo |
ALX-164-005-M001 |
Obestatin (mouse, rat)
|
1mg |
|
|
| Enzo |
ALX-165-004-M001 |
pp60v-src (137-157)
|
1mg |
|
|
| Enzo |
ALX-164-005-M005 |
Obestatin (mouse, rat)
|
5mg |
|
|
| Enzo |
ALX-163-003-P001 |
NPY (human)
|
1mg* |
|
|
| Enzo |
ALX-163-003-PC05 |
NPY (human)
|
0.5mg* |
|
|
| Enzo |
ALX-163-011-1 |
NBD peptide / NF kappa B blocker (cell permeable)
|
1Vial |
|
|
| Enzo |
ALX-164-004-M001 |
Obestatin (human)
|
1mg |
|
|
| Enzo |
ALX-164-001-C100 |
Orexin A (human, bovine, rat, mouse)
|
100µg |
|
|
| Enzo |
ALX-164-001-M001 |
Orexin A (human, bovine, rat, mouse)
|
1mg |
|
|
| Enzo |
ALX-163-001-P005 |
Nociceptin
|
5mg* |
|
|
| Enzo |
ALX-163-001-P001 |
Nociceptin
|
1mg* |
|
|
| Enzo |
ALX-163-002-P005 |
Neurotensin
|
5mg* |
|
|
| Enzo |
ALX-163-002-P001 |
Neurotensin
|
1mg* |
|
|
| Enzo |
ALX-162-034-C500 |
MALP 2 (BULK)
|
500µg |
|
|
| Enzo |
ALX-162-033-M001 |
Myelin basic protein (human, bovine, rat) (87-99)
|
1mg |
|
|
| Enzo |
ALX-162-031-M001 |
Myelin proteolipid protein (human, bovine, dog, mouse, rat) (139-151)
|
1mg |
|
|
| Enzo |
ALX-162-030-M001 |
Myelin oligodendrocyte glycoprotein (35-55) (mouse, rat)
|
1mg |
|
|
| Enzo |
ALX-162-027-C050 |
MALP 2
|
50µg |
|
|
| Enzo |
ALX-162-030-MC05 |
Myelin oligodendrocyte glycoprotein (35-55) (mouse, rat)
|
0.5mg |
|
|
| Enzo |
ALX-162-017-M001 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
1mg |
|
|
| Enzo |
ALX-162-017-M005 |
N-Myristoyl-Lys-Arg-Thr-Leu-Arg-OH
|
5mg |
|
|
| Enzo |
ALX-162-013-M001 |
Myosin light chain kinase substrate
|
1mg |
|
|
| Enzo |
ALX-162-011-M001 |
Myosin light chain kinase (11-19) amide
|
1mg |
|
|
| Enzo |
ALX-162-009-M001 |
Myelin basic protein (bovine) (4-14)
|
1mg |
|
|
| Enzo |
ALX-162-009-M005 |
Myelin basic protein (bovine) (4-14)
|
5mg |
|
|
| Enzo |
ALX-162-007-M001 |
Melittin (synthetic)
|
1mg |
|
|
| Enzo |
ALX-162-007-MC05 |
Melittin (synthetic)
|
0.5mg |
|
|
| Enzo |
ALX-162-006-M001 |
Melittin (natural)
|
1mg |
|
|
| Enzo |
ALX-162-006-M005 |
Melittin (natural)
|
5mg |
|
|